Return to top of page

Alzheimer’s Disease and Related Dementias

Dementia is a general term to describe a person experiencing memory loss, language and problem solving difficulties, and other cognitive decline that negatively impacts their life. Alzheimer’s disease is the most common form of dementia, affecting an estimated 6.2 million Americans over 65. Other forms of dementia include Dementia with Lewy Bodies (DLB), Parkinson’s Disease Dementia, Vascular Dementia, Frontotemporal Dementia (FTD), and Huntington’s Disease. Dementia is not a normal part of aging, though it primarily impacts older adults.

Unfortunately, there is currently no cure for dementia. But there are treatments available to alleviate and manage the symptoms of dementia, such as behavioral changes and anxiety. Accordingly, we must have a healthcare system that provides adequate care and support for people living with dementia and their families.

If you want to learn more about dementia research and clinical trials, we encourage you to visit’s clinical trial finder page. The webpage provides resources for helping patients better understand clinical research and identify trials for which participation may be appropriate. 

The Alliance for Aging Research works on several projects to address current obstacles in the lack of treatments for dementia and adequate care for this patient group.


Founded in 2005, the Accelerate Cure/Treatments for All Dementias (ACT-AD) Coalition is a group of more than 50 national nonprofit organizations, chaired by the Alliance for Aging Research, urgently working to speed up the development of potential cures and more effective treatments for all dementias.

Project PAUSE

Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness) is an ad hoc coalition of national patient and professional organizations collectively addressing long-term care clinical regulatory and legislative issues. Project PAUSE provides educational opportunities for policymakers and the public on practical solutions to improve clinical care in long-term care settings and improve the diagnosis and management of neuropsychiatric symptoms (NPS) of dementia.

ACT-AD logo.
Leaders Engaged on Alzheimer's Disease logo.

Videos on Alzheimer’s Disease and Related Dementias

Watch video

Discussing Mental Health with Geriatric Neuropsychiatrist Dr. Dilip Jeste for This is Growing Old

May is Mental Health Awareness Month as well as Older Americans Month. This critical intersection implores us to explore emotional…

Watch video

Rally for Access

In June 2021, the Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s disease–the first new…

Watch video

CMS’ Coverage Decision: It’s Not Just About Alzheimer’s Disease

On February 9, the Alliance for Aging Research hosted a panel discussion on CMS’ decision to restrict coverage for drugs…


The Healthy Aging Blog on Alzheimer’s Disease and Related Dementias

USAgainstAlzheimer’s Shares FAQs About their Important BrainGuide Tool

This Mental Health Awareness Month, Learn More About Having Important Conversations

Doctor analyzing brain scans.

Alzheimer’s Disease Policy Task Force Submits Comments on Draft Medicare Coverage Decision for Monoclonal Antibodies Targeting Amyloid

"This is Growing Old" podcast cover.

45. David Farber Weighs in on CMS’ Recent National Coverage Determination Proposal

This is Growing Old

News and Updates on Alzheimer’s Disease and Related Dementias

Candid Seal of Platinum Transparency 2022

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator logo

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.